Before Canada legalized marijuana in 2018, Canopy Growth (NASDAQ: CGC) was seen as a top cannabis stock, an industry leader, and arguably one of the best stocks to invest in for people who were ...

Canopy Growth (CGC) shares have been in a sharp uptrend this week following reports President Donald Trump will reclassify cannabis as a “Schedule III” drug within the next few days. Additionally, the ...

Canopy Growth Corporation (CGC) ended the recent trading session at $1.16, demonstrating a -4.13% change from the preceding day's closing price. This change lagged the S&P 500's 0.14% loss on the day.

Canopy Growth (NASDAQ: CGC) is one of the top cannabis companies in the Nasdaq Composite. Unfortunately, that's not enough to suggest that it's a safe investment -- or that it's profitable, or that ...

Canopy says revenue from international cannabis markets increased 32% year-over-year to $12 million, driven by growth in Germany and Poland. Canopy's Canada medical cannabis segment delivered a fifth ...

Canopy Growth's recent results show that the company has been making strides in improving its bottom line and decreasing cash burn. Top-line growth has been more difficult, given the company's ...

Canopy Growth Corporation (CGC) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Earlier this month, Canopy Growth announced the Canada-wide launch of Claybourne Gassers liquid diamond AIO vapes and Frosted Flyers infused pre-roll variety packs, targeting both recreational and ...

Canopy Growth's cash burn is high but could improve as the company stops funding BioSteel. Dilution, however, may become a much bigger problem for investors in the future. Earlier this year, the ...

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of ...